3 of the Fastest-Growing Stocks on the Planet in 2026

Three high-growth technology names are forecast to deliver triple‑digit revenue gains in 2026: AST SpaceMobile (ASTS) is projected to grow to $235.6m in 2026 after an estimated 1,200% jump to $57.3m in 2025 and a further 311% in 2026, Rigetti Computing (RGTI) is expected to rise from ~$7.6m in 2025 to $20.5m in 2026 (169%), and Nebius Group (NBIS) is forecast to surge from ~$556m in 2025 to $3.45bn in 2026 (521%). The piece flags meaningful upside drivers—large telecom and hyperscaler partnerships (Nebius cited $17.4bn with Microsoft and ~$3bn with Meta)—but emphasizes execution risks, unsustainable valuations (AST $33.3bn market value cited), ongoing losses, and bubble concerns for AI and quantum-themed stocks, implying cautious investor positioning despite headline revenue trajectories.

Analysis

Market structure: The AI/data-center and cloud winners (MSFT, AMZN, NVDA, large hyperscalers) capture the bulk of demand while specialist capital-intensive entrants (NBIS, ASTS) compete on capacity and contracts rather than retail share. Nebius’s $17.4B Microsoft and ~$3B Meta deals signal a supply-constrained AI-infra cycle where pricing power can persist for 12–36 months, boosting chipmakers and colo vendors but raising bar for new entrants’ unit economics.

Risk assessment: Tail risks include satellite launch failure or production cost overruns for ASTS, quantum commercialization delays for RGTI, and an AI demand re-rating if adoption stalls — any of which could produce >50% drawdowns for these names within 3–12 months. Near-term (30–90 days) volatility hinges on launch manifests, earnings cadence and Fed guidance; medium-term (6–18 months) risks are contract concentration (Nebius) and capital raises; long-term (2–5 years) outcomes depend on technical viability and margin expansion.

Trade implications: Short-duration defined-risk bearish trades on ASTS and RGTI (3–9 month put spreads sized 1–2% each) exploit extreme P/S (>140x implied for ASTS 2026 sales) while allocating 2–4% long to MSFT/AMZN for diversified AI exposure. Consider pair: long MSFT (3%) vs short NBIS (2%) to capture counterparty/diversification premium; hedge portfolio tail risk with 0.5–1% long VIX calls or 3–6 month SPX puts.

Contrarian angles: Consensus underprices execution/concentration risk — NBIS revenue is highly counterparty-dependent and ASTS valuation assumes flawless launches; conversely, a technical breakthrough in quantum or a flawless AST launch within 90 days could spark >100% rallies, so keep asymmetric, low-cost hedges. History (2000 tech bubble, 2019–21 cloud froth) suggests mean reversion in single-name valuations; size positions small and prefer defined-risk option structures.

Key Decisions for Investors

• Establish a 1–2% portfolio short exposure to ASTS via a 3–6 month put spread (buy ~25-delta put, sell ~12-delta) to capture valuation compression (current market cap ~$33.3B vs 2026 sales $235.6M → P/S >140).
• Buy 6–9 month puts or put spreads on RGTI sized 1.5–2% of portfolio to exploit binary tech and commercialization risk; set a profit-taking target of 40–60% premium decline and stop-loss at 100% of option premium.
• Allocate 2–3% long to MSFT or AMZN (scale in over 4–6 weeks) for diversified AI infrastructure exposure; trim on a 20–30% rally and re-evaluate if Fed rate-cut expectations move materially within 90 days.
• Implement a pair trade: long MSFT (3% weight) vs short NBIS (2% weight) for 6–12 months to harvest counterparty/diversification premium and guard against concentrated-contract execution risk in NBIS.
• Reserve 0.5–1% capital to buy 3–6 month VIX call spreads or SPX puts as tail insurance ahead of key catalysts (satellite launch windows, quarterly earnings over next 60–120 days) to protect against a sudden bubble unwind.